|Bioquell plc -- USA Stock|| |
USD 3.50 0.00 0.00%
Independent Non-Executive Chairman of the Board
Mr. Nigel J. Keen is an Independent NonExecutive Chairman of the Board of Bioquell PLC. since 2009. He Joined the Board in March 2008 and was appointed Chairman in 2009. He gained a degree in Engineering from Cambridge University and also qualified as an accountant with Deloitte. He has pursued a career encompassing industry VC and banking. He is Chairman of Oxford Instruments Plc and Deltex Medical Group Plc.
Age: 63 Chairman Since 2009
44 1264 835 900 http://www.bioquellplc.com
The company has return on total asset (ROA)
of 5.32 %
which means that it generated profit of $5.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 5.16 %
meaning that it generated $5.16 on every $100 dollars invested by stockholders.
Bioquell PLC designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services to the pharmaceutical, healthcare, food, and defense industries in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc is traded on OTC Market in USA.Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in 52 Royce Close and employs 200 people.
Bioquell plc Leadership Team
Stock Performance Indicators